Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait

Fatemah Alhaddad 1, Ali Abdulkareem 1, Danah Alsharrah 1, Abdullah Alkandari 2, Saadoun Bin-Hasan 1 2, Mona Al-Ahmad 3, Hashem Al Hashemi 1, Mohammad Alghounaim 4

Affiliations

28 June 2022

-

doi: 10.1136/bmjopen-2021-056371

Abstract

Objective: Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children.

Design: This is a population-level retrospective cohort study.

Setting: Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait.

Participants: The study included children 12 years and younger between 28 February 2020 and 6 March 2021. SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart. Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait.

Primary and secondary outcome measures: The primary measure is to estimate SARS-CoV-2 PCR repositivity rate. The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection. Descriptive statistics were used to present clinical data for each infection episode. Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals.

Results: Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.02 (95% CI 0.71 to 1.45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62-128.75) days. The incidence of reinfection decreased to 0.78 (95% CI 0.52 to 1.17) and 0.47 (95% CI 0.28 to 0.79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively. The mean age of reinfected subjects was 8.5 (IQR 3.7-10.3) years and the majority (70%) were girls. Most children (55.2%) had asymptomatic reinfection. Fever was the most common presentation in symptomatic patients. One immunocompromised experienced two reinfection episodes.

Conclusion: SARS-CoV-2 reinfection is uncommon in children. Previous confirmed COVID-19 in children seems to result in a milder reinfection.

Keywords: COVID-19; Epidemiology; PAEDIATRICS.

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1 Flow diagram of the study population.

Figure 1 Flow diagram of the study population.

Figure 2 Duration between first SARS-CoV-2 infection and subsequent infections. The shaded bars represent the duration between positive PCR results. Patient 6 had two episodes of reinfection.

Figure 2 Duration between first SARS-CoV-2 infection and subsequent infections. The shaded bars represent the duration between positive PCR results. Patient 6 had two episodes of reinfection.

Similar articles

Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.

Medic S, Anastassopoulou C, Lozanov-Crvenkovic Z, Dragnic N, Petrovic V, Ristic M, Pustahija T, Tsakris A, Ioannidis JPA.JAMA Netw Open. 2023 Feb 1;6(2):e2255779. doi: 10.1001/jamanetworkopen.2022.55779.PMID: 36780157 Free PMC article.

Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait.

Al-Ahmad M, Alowayesh M, Al Awadi A, Alghounaim M, Al Hashemi H, Al Enezi L, Rawdhan H, Rodriguez-Bouza T.East Mediterr Health J. 2023 Feb 26;29(2):146-150. doi: 10.26719/emhj.23.015.PMID: 36880496 Review.

Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.

Kubale J, Balmaseda A, Frutos AM, Sanchez N, Plazaola M, Ojeda S, Saborio S, Lopez R, Barilla C, Vasquez G, Moreira H, Gajewski A, Campredon L, Maier HE, Chowdhury M, Cerpas C, Harris E, Kuan G, Gordon A.JAMA Netw Open. 2022 Jun 1;5(6):e2218794. doi: 10.1001/jamanetworkopen.2022.18794.PMID: 35759261 Free PMC article.

Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.

Slezak J, Bruxvoort K, Fischer H, Broder B, Ackerson B, Tartof S.Clin Microbiol Infect. 2021 Dec;27(12):1860.e7-1860.e10. doi: 10.1016/j.cmi.2021.07.030. Epub 2021 Aug 19.PMID: 34419576 Free PMC article.

Quantifying the risk of SARS-CoV-2 reinfection over time.

O Murchu E, Byrne P, Carty PG, De Gascun C, Keogan M, O'Neill M, Harrington P, Ryan M.Rev Med Virol. 2022 Jan;32(1):e2260. doi: 10.1002/rmv.2260. Epub 2021 May 27.PMID: 34043841 Free PMC article. Review.

Cited by

Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis.

Deng J, Ma Y, Liu Q, Du M, Liu M, Liu J.Int J Environ Res Public Health. 2023 Feb 14;20(4):3335. doi: 10.3390/ijerph20043335.PMID: 36834029 Free PMC article. Review.

Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.

Medic S, Anastassopoulou C, Lozanov-Crvenkovic Z, Dragnic N, Petrovic V, Ristic M, Pustahija T, Tsakris A, Ioannidis JPA.JAMA Netw Open. 2023 Feb 1;6(2):e2255779. doi: 10.1001/jamanetworkopen.2022.55779.PMID: 36780157 Free PMC article.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Samudrala PK, Kumar P, Choudhary K, et al. . Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol 2020;883:173375. 10.1016/j.ejphar.2020.173375 - DOI - PMC - PubMed
  2.  
    1. WHO coronavirus disease (COVID-19) Dashboard. World Health organization. World Health organization. Available: https://covid19.who.int/ [Accessed 1 May 2021].
  3.  
    1. Leidman E, Duca LM, Omura JD, et al. . COVID-19 Trends Among Persons Aged 0-24 Years - United States, March 1-December 12, 2020. MMWR Morb Mortal Wkly Rep 2021;70:88–94. 10.15585/mmwr.mm7003e1 - DOI - PMC - PubMed
  4.  
    1. Children and COVID-19: State Data Report . American Academy of Pediatrics and the Children’s Hospital Association. Available: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infect... [Accessed 12 May 2021].
  5.  
    1. CDC COVID-19 Response Team . Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep 2020;69:422–6. 10.15585/mmwr.mm6914e4 - DOI - PMC - PubMed
  6.  
    1. Lee P-I, Hu Y-L, Chen P-Y, et al. . Are children less susceptible to COVID-19? J Microbiol Immunol Infect 2020;53:371–2. 10.1016/j.jmii.2020.02.011 - DOI - PMC - PubMed
  7.  
    1. Alsharrah DY, Al-Haddad F, Aljamaan S. 441. clinical characteristics of pediatric SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) in Kuwait. open forum infectious diseases. Oxford University Press US, 2020: S288.
  8.  
    1. Parry J. Covid-19: Hong Kong scientists report first confirmed case of reinfection. BMJ 2020;370:m3340. 10.1136/bmj.m3340 - DOI - PubMed
  9.  
    1. Abu-Raddad LJ, Chemaitelly H, Coyle P, et al. . SARS-CoV-2 reinfection in a cohort of 43. 000 antibody-positive individuals followed for up to 35 weeks. medRxiv 2021.
  10.  
    1. Lumley SF, O'Donnell D, Stoesser NE, et al. . Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med 2021;384:533–40. 10.1056/NEJMoa2034545 - DOI - PMC - PubMed
  11.  
    1. Hall VJ, Foulkes S, Charlett A. Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? large multi-centre prospective cohort study (the siren study), England: June to November 2020. medRxiv 2020. 10.1101/2021.01.13.21249642 - DOI
  12.  
    1. European Centre for Disease Prevention and Control . Reinfection with SARS-CoV: considerations for public health response. Available: https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-... [Accessed 15 Apr 2021].
  13.  
    1. Pan American Health Organization/ World Health Organization . Interim guidelines for detecting cases of reinfection by SARS-CoV-2. Available: https://www.paho.org/en/documents/interim-guidelines-detecting-cases-rei... [Accessed 15 Apr 2021].
  14.  
    1. Multisystem inflammatory syndrome in children and adolescents with COVID-19. World Health organization. Available: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrom... [Accessed 10 Apr 2021].
  15.  
    1. WHO . Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization, 2020.
  16.  
    1. European Centre for Disease Prevention and Control . Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA. Available: https://www.ecdc.europa.eu/en/publications-data/reinfection-sars-cov-2-i... [Accessed 8 April 2021].
  17.  
    1. Hansen CH, Michlmayr D, Gubbels SM, et al. . Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet 2021;397:1204–12. 10.1016/S0140-6736(21)00575-4 - DOI - PMC - PubMed
  18.  
    1. Dong Y, Mo X, Hu Y. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatr 2020. 10.1542/peds.2020-0702 - DOI
  19.  
    1. Bajaj V, Gadi N, Spihlman AP, et al. . Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Front Physiol 2020;11:571416. 10.3389/fphys.2020.571416 - DOI - PMC - PubMed
  20.  
    1. Wang X, Guo X, Xin Q, et al. . Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients. Clin Infect Dis 2020;71:2688–94. 10.1093/cid/ciaa721 - DOI - PMC - PubMed
  21.  
    1. Chia WN, Zhu F, Ong SWX, et al. . Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study. Lancet Microbe 2021;2:e240–9. 10.1016/S2666-5247(21)00025-2 - DOI - PMC - PubMed
  22.  
    1. Lau EHY, Tsang OTY, Hui DSC, et al. . Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun 2021;12:63. 10.1038/s41467-020-20247-4 - DOI - PMC - PubMed
  23.  
    1. Weisberg SP, Connors TJ, Zhu Y, et al. . Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol 2021;22:25–31. 10.1038/s41590-020-00826-9 - DOI - PMC - PubMed
  24.  
    1. Hodinka RL, Kaiser L, Hodinka RL. Point: is the era of viral culture over in the clinical microbiology laboratory? J Clin Microbiol 2013;51:2–8. 10.1128/JCM.02593-12 - DOI - PMC - PubMed
  25.  
    1. AlGhounaim M, Xiao Y, Caya C, et al. . Diagnostic yield and clinical impact of routine cell culture for respiratory viruses among children with a negative multiplex RT-PCR result. J Clin Virol 2017;94:107–9. 10.1016/j.jcv.2017.07.015 - DOI - PMC - PubMed
  26.  
    1. Abu-Raddad LJ, Chemaitelly H, Malek JA, et al. . Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense Reexposure setting. Clin Infect Dis 2021;73:e1830–40. 10.1093/cid/ciaa1846 - DOI - PMC - PubMed
  27.  
    1. Cohen JI, Burbelo PD. Reinfection with SARS-CoV-2: implications for vaccines. Clin Infect Dis 2021;73:e4223–8. 10.1093/cid/ciaa1866 - DOI - PMC - PubMed
  28.  
    1. Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA 2020;323:2249–51. 10.1001/jama.2020.8259 - DOI - PubMed
  29.  
    1. Wajnberg A, Mansour M, Leven E, et al. . Humoral response and PCR positivity in patients with COVID-19 in the new York City region, USA: an observational study. Lancet Microbe 2020;1:e283–9. 10.1016/S2666-5247(20)30120-8 - DOI - PMC - PubMed
  30.  
    1. He J, Guo Y, Mao R, et al. . Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta-analysis. J Med Virol 2021;93:820–30. 10.1002/jmv.26326 - DOI - PMC - PubMed
  31.  
    1. Pouwels KB, Pritchard E, Matthews PC, et al. . Effect of delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nat Med 2021;27:2127–35. 10.1038/s41591-021-01548-7 - DOI - PMC - PubMed

Page Navigation